Minapharm Pharmaceuticals
Last Updated:
- 260.00 EGP
- -0.23
- -0.09%
مينا فارم للأدوية والصناعات الكيماوية
مينا فارم للأدوية
Symbol :
MIPH
ISIN :
EGS380G1C011
52-Week Range :
145.00
-
279.00
Turnover Ratio :
0.07
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Minapharm Pharmaceuticals is a public company, listed on Egyptian Exchange (EGX) since January 2004. It operates within the pharmaceuticals, biotechnology & life sciences sector focusing on pharmaceuticals....
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :EGS380G1C011
-
Contact Person :
-
Established On:01-Oct-1986
-
Stock Listing On :11-Jan-2004
-
No of Employees :1,084 Employees as of 2024
-
Outstanding Shares :12,293,440
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Leave | 2023 | EGX 50 EWI | Egyptian Exchange |
| Join | 2022 | EGX 50 EWI | Egyptian Exchange |
| Join | 2020 | Health Care & Pharmaceuticals | Egyptian Exchange |
| Join | 2011 | EGX 70 | Egyptian Exchange |
| Join | 2004 | Egyptian Exchange |
| Minapharm Pharmaceuticals |
| El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo - Egypt |
| T : +20 2 24143171 |
| F : +20 2 24143179 |
| www.minapharm.com |
| mailbox@minapharm.com |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman and Managing Director: | Wafik El Bardisy | 2025 |
| Deputy Chairman: | Amr El Shabrawishy | 2025 |
| Managing Director: | Shaheer El Bardisy | 2025 |
| Board Member: | Anwar Mikhail | |
| Mahmoud Sayed | 2024 | |
| Nihal Albrdesa | 2025 | |
| Ahmed Rady | 2025 | |
| Mona El Shabrawishy | 2025 |
Reports
| Date | Title | File |
|---|---|---|
| 2025 | Minapharm Pharmaceuticals Quarterly Financials Report Q2 2025 | |
| 2025 | Minapharm Pharmaceuticals Non- consolidated Quarterly Financials Report Q2 2025 | |
| 2025 | Minapharm Pharmaceuticals Quarterly Financials Report Q1 2025 | |
| 2025 | Minapharm Pharmaceuticals Non- consolidated Quarterly Financials Report Q1 2025 | |
| 2025 | Minapharm Pharmaceuticals Annual Financials Report 2024 | |
| 2025 | Minapharm Pharmaceuticals Non- consolidated Annual Financials Report 2024 | |
| 2024 | Minapharm Pharmaceuticals Quarterly Financials Report Q3 2024 | |
| 2024 | Minapharm Pharmaceuticals Non- consolidated Quarterly Financials Report Q3 2024 | |
| 2024 | Minapharm Pharmaceuticals Quarterly Financials Report Q2 2024 | |
| 2024 | Minapharm Pharmaceuticals Non- consolidated Quarterly Financials Report Q2 2024 | |
| 2024 | Minapharm Pharmaceuticals Quarterly Financials Report Q1 2024 |
